Processing 00000000.tx.1: Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behet's disease J. 

Phrase: "Association of specific interleukin 1 gene cluster polymorphisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "with increased susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0012655:Susceptibility [Clinical Attribute]
   861   C0220898:Susceptibility [Organism Attribute]
   861   C1264642:Susceptibility [Functional Concept]
   861   C1547045:*Susceptibility [Quantitative Concept]
   789 E C0231204:Susceptible [Functional Concept]
   789 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "for Behet's disease J."
Processing 00000000.tx.2: Karasneh, A. 

Phrase: "Karasneh,"

Phrase: "A."
Processing 00000000.tx.3: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: Hajeer, J. 

Phrase: "Hajeer,"

Phrase: "J."
Processing 00000000.tx.5: Barrett1, W. 

Phrase: "Barrett1,"

Phrase: "W."
Processing 00000000.tx.6: E. 

Phrase: "E."
Processing 00000000.tx.7: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.8: Ollier, M. 

Phrase: "Ollier,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.9: Thornhill2 and A. 

Phrase: "Thornhill2"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.10: Gul3 ARC Epidemiology Unit, University of Manchester, Manchester, 1 ICRF Genetic Epidemiology Laboratory, St James's University Hospital, Leeds, 2 Oral Disease Research Centre, Bart's and the London, Queen Mary's School of Medicine and Dentistry, UK and 3 Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey  Abstract Top Abstract Introduction Patients and methods Results Discussion References  Objective. 

Phrase: "Gul3 ARC Epidemiology Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0439148:Unit [Quantitative Concept]
   812   C1519795:Unit [Quantitative Concept]
   812   C1704753:Unit [Manufactured Object]
   812   C1880519:Unit [Quantitative Concept]

Phrase: "University of Manchester,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Manchester,"

Phrase: "1 ICRF Genetic Epidemiology Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0022877:Laboratory [Manufactured Object,Organization]
   804   C3244292:laboratory [Functional Concept]

Phrase: "St James's University Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1510665:Hospital [Qualitative Concept]
   812   C3272372:ST [Intellectual Product]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "Leeds,"

Phrase: "2 Oral Disease Research Centre,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0683939:research center [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]

Phrase: "Bart's"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424344:BART [Gene or Genome]
  1000   C1424778:BART [Gene or Genome]

Phrase: "and"

Phrase: "the London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "Queen Mary's School of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Dentistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011438:Dentistry [Biomedical Occupation or Discipline]

Phrase: "UK"

Phrase: "and"

Phrase: "3 Division of Rheumatology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "Department of Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Istanbul Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015535:Faculty [Professional or Occupational Group]

Phrase: "Istanbul University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Istanbul,"

Phrase: "Turkey  Abstract Top Abstract Introduction Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Objective."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018017:Objective [Intellectual Product]
  1000   C1571702:Objective [Qualitative Concept]
Processing 00000000.tx.11: The aim of this study was to investigate if the inheritance of specific polymorphisms of interleukin 1 (IL-1) A, IL-1B and IL-1 receptor antagonist (IL-1RN) genes could affect the susceptibility to Behet's disease (BD). 

Phrase: "The aim of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1947946:Aim [Idea or Concept]
   760   C2948600:Aim [Pharmacologic Substance]
   760   C3540471:AIM [Gene or Genome]
   760   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "if"

Phrase: "the inheritance of specific polymorphisms of interleukin 1 (IL-1) A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0242538:Inheritance [Quantitative Concept]
   742   C0728826:Inheritance [Functional Concept]

Phrase: "IL-1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "IL-1 receptor antagonist"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1416402:INTERLEUKIN 1 RECEPTOR ANTAGONIST [Gene or Genome]
  1000   C1704264:interleukin-1 receptor antagonist [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C3536785:Interleukin-1 Receptor Antagonist [Pharmacologic Substance]
   812   C0231491:Antagonist [Organ or Tissue Function]
   756   C0063710:Interleukin 1 Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   756   C1416395:INTERLEUKIN 1 RECEPTOR [Gene or Genome]
   712 E C0680242:antagonism [Social Behavior]
   708   C0206553:Interleukin Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "(IL-1RN"

Phrase: ")"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "could"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the susceptibility to Behet's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "(BD"

Phrase: ")."
Processing 00000000.tx.12: Methods. 

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.13: A total of 132 BD patients and 105 healthy controls were genotyped for IL-1A -889, IL-1B -511, -35, +5810, +5887, and IL-1RN +8006, +8061, +9589, +11100 single nucleotide polymorphisms, and IL-1RN 86-bp variable number of tandem repeat polymorphism. 

Phrase: "A total of 132 BD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "105 healthy controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C2986479:Healthy Control [Qualitative Concept]
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "genotyped for IL-1A -889,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0450344:1A [Intellectual Product]
   760   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1553633:1a [Medical Device]
   726   C0017431:Genotype [Organism Attribute]

Phrase: "IL-1B -511, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0450345:1B [Intellectual Product]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "35,"

Phrase: "+5810,"

Phrase: "+5887,"

Phrase: "and"

Phrase: "IL-1RN +8006,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "+8061,"

Phrase: "+9589,"

Phrase: "+11100 single nucleotide polymorphisms,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "IL-1RN 86-bp variable number of tandem repeat polymorphism."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0242827:Variable Number Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   797   C1710347:Variable Number Tandem Repeat [Cell or Molecular Dysfunction]
   777   C3179163:Variable Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0237753:*Number [Quantitative Concept]
   739   C0439828:Variable [Qualitative Concept]
   739   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.14: 2-analysis was used to compare the allele and genotype frequencies of the cases and controls. 

Phrase: "2-analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "genotype frequencies of the cases"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.15: IL-1A and IL-1B haplotypes were reconstructed using the Phase program. 

Phrase: "IL-1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "IL-1B haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "reconstructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348043:Reconstructed [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Phase program."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]
Processing 00000000.tx.16: Results. 

Phrase: "Results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.17: Inheritance of the C allele of the IL-1A -889 polymorphism was associated with BD (OR=2.0, P=0.01) and inheritance of the IL-1A -889C/IL-1B +5887T haplotype was identified as an increased risk for BD. 

Phrase: "Inheritance of the C allele of the IL-1A -889 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0242538:Inheritance [Quantitative Concept]
   738   C0728826:Inheritance [Functional Concept]

Phrase: "was"

Phrase: "associated with BD (OR"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0028873:Odds Ratios [Quantitative Concept]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0456603:Ratios [Quantitative Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1547037:Ratio [Intellectual Product]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "=2.0,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "inheritance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242538:Inheritance [Quantitative Concept]
  1000   C0728826:Inheritance [Functional Concept]

Phrase: "of the IL-1A -889C/IL-1B +5887T haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0018591:Haplotype [Organism Attribute]

Phrase: "was"

Phrase: "identified as an increased risk"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0205396:Identified [Qualitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "for BD."
Processing 00000000.tx.18: The IL-1A -889 and IL-1B +5887 CC/TT combined genotype was significantly more observed in BD cases than in controls (57.5 vs 38.1%, OR=2.2, P=0.003). 

Phrase: "The IL-1A -889"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0450344:1A [Intellectual Product]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "IL-1B +5887 CC/TT"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "was"

Phrase: "significantly more"

Phrase: "observed in BD cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "than"

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(57.5"

Phrase: "vs"

Phrase: "38.1%,"

Phrase: "OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=2.2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "P=0.003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.19: No association with BD was found for other investigated polymorphisms in the IL-1B and IL-1RN genes. 

Phrase: "No association with BD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "found for other investigated polymorphisms"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0032529:polymorphisms [Genetic Function]
   760   C0150312:Found [Quantitative Concept]
   760   C1292732:investigated [Functional Concept]
   726 E C0243095:Find [Finding]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in the IL-1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "IL-1RN genes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C1334205:Interleukin Gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.20: Conclusion. 

Phrase: "Conclusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]
Processing 00000000.tx.21: Susceptibility to BD is increased in individuals carrying both the IL-1A -889C and IL-1B +5887T haplotype. 

Phrase: "Susceptibility to BD"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0012655:Susceptibility [Clinical Attribute]
   790   C0220898:Susceptibility [Organism Attribute]
   790   C1264642:Susceptibility [Functional Concept]
   790   C1547045:*Susceptibility [Quantitative Concept]
   718 E C0231204:Susceptible [Functional Concept]
   718 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "is"

Phrase: "increased in individuals"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "both the IL-1A -889C"

Phrase: "and"

Phrase: "IL-1B +5887T haplotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.22: Individuals who are both homozygous CC at IL-1A -889 and TT at IL-1B +5887 appear to have twice the risk of developing BD as individuals having other IL-1A -889/IL-1B +5887 genotypes. 

Phrase: "Individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "who"

Phrase: "are"

Phrase: "both homozygous CC at IL-1A -889"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3538933:CC [Cell Component]

Phrase: "and"

Phrase: "TT at IL-1B +5887"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "twice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "the risk of developing BD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "as individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "having"

Phrase: "other IL-1A -889/IL-1B +5887 genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.23: KEY WORDS: Behet's disease, Interleukin 1, IL-1 receptor antagonist, Single nucleotide polymorphism, Haplotype.  

Phrase: "KEY WORDS"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "Behet's disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Interleukin 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "IL-1 receptor antagonist,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1416402:INTERLEUKIN 1 RECEPTOR ANTAGONIST [Gene or Genome]
  1000   C1704264:interleukin-1 receptor antagonist [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C3536785:Interleukin-1 Receptor Antagonist [Pharmacologic Substance]
   812   C0231491:Antagonist [Organ or Tissue Function]
   756   C0063710:Interleukin 1 Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   756   C1416395:INTERLEUKIN 1 RECEPTOR [Gene or Genome]
   712 E C0680242:antagonism [Social Behavior]
   708   C0206553:Interleukin Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "Single nucleotide polymorphism,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:Polymorphism [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "Haplotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.24: Introduction Top Abstract Introduction Patients and methods Results Discussion References  Behet's disease is an unclassified systemic vasculitis of unknown cause with recurrence of various symptoms and a chronic course. 

Phrase: "Introduction Top Abstract Introduction Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "an unclassified systemic vasculitis of unknown cause"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0264939:Systemic Vasculitis [Finding]
   748   C0042384:Vasculitis [Disease or Syndrome]
   748   C0205373:Systemic [Functional Concept]
   748   C1963274:Vasculitis [Finding]

Phrase: "with recurrence"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0034897:Recurrence [Phenomenon or Process]
  1000   C1458156:recurrence [Neoplastic Process]
  1000   C2825055:Recurrence [Pathologic Function]
   928 E C2945760:Recurrent [Temporal Concept]

Phrase: "of various symptoms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]

Phrase: "and"

Phrase: "a chronic course."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750729:Course [Temporal Concept]
Processing 00000000.tx.25: Behet's disease was originally described as a triad of oral and genital ulcers and uveitis, but is now recognized as a systemic disease affecting all types and sizes of blood vessels, eyes, central nervous system, joints, lungs and intestines [13]. 

Phrase: "Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "originally"

Phrase: "described as a triad of oral"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0076994:triad [Biomedical or Dental Material,Organic Chemical]
   753   C0442027:Oral [Spatial Concept]
   753   C1179122:triad [Cell Component]
   753   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "genital ulcers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0151281:Genital ulcers [Disease or Syndrome]
   861   C0041582:ULCERS [Pathologic Function]

Phrase: "and"

Phrase: "uveitis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042164:Uveitis [Disease or Syndrome]
  1000   C1963266:Uveitis [Finding]

Phrase: "but"

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "recognized as a systemic disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0442893:Systemic disease [Disease or Syndrome]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205373:Systemic [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "all types"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332307:Types [Qualitative Concept]
   966 E C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "sizes of blood vessels,"
Meta Candidates (Total=13; Excluded=10; Pruned=0; Remaining=3)
   833   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   799 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   799 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   770   C0456389:SIZES [Spatial Concept]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]
   740 E C0005767:Blood [Tissue]
   740 E C0005768:blood [Body Substance]
   740 E C0229664:Blood [Body Substance]
   740 E C0392895:Bloods [Population Group]
   722 E C0333275:Bloody [Qualitative Concept]

Phrase: "eyes,"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
  1000   C0015392:Eyes [Body Part, Organ, or Organ Component]
   966 E C1280202:Eye [Body Part, Organ, or Organ Component]
   928 E C0029144:optic [Occupation or Discipline]
   928 E C0042789:Ocular [Organism Function]
   928 E C1299003:Ocular [Spatial Concept]
   900 E C0014236:Ophthalmia [Disease or Syndrome]
   900 E C0700042:Oculus [Body Location or Region]

Phrase: "central nervous system,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "joints,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0022417:Joints [Body Space or Junction]
  1000   C0392905:Joints [Body System]
   966 E C1269611:Joint [Body Space or Junction]
   966 E C1706309:Joint [Medical Device]
   928 E C0521339:Articular [Functional Concept]

Phrase: "lungs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   966 E C0819757:LUNG [Tissue]
   966 E C1278908:Lung [Body Part, Organ, or Organ Component]
   928 E C2707265:Pulmonary [Clinical Attribute]
   928 E C2709248:Pulmonary [Qualitative Concept]
   900 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "and"

Phrase: "intestines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0021853:Intestines [Body Part, Organ, or Organ Component]
   966 E C1708548:INTESTINE [Tissue]

Phrase: "[13"

Phrase: "]."
Processing 00000000.tx.26: Behet's disease has a worldwide distribution, but it is most common in Japan, the Middle East and the Mediterranean, i.e. countries along the ancient Silk Road. 

Phrase: "Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "a worldwide distribution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "most common in Japan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]

Phrase: "the Middle East"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026068:Middle East [Geographic Area]
   861   C1707877:East [Spatial Concept]

Phrase: "and"

Phrase: "the Mediterranean,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0240321:Mediterranean [Population Group]

Phrase: "i.e. countries along the ancient Silk Road."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0454664:Countries [Geographic Area]
Processing 00000000.tx.27: The prevalence of Behet's disease in Turkey is particularly high at 0.83.7/1000 [4, 5]. 

Phrase: "The prevalence of Behet's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033105:Prevalence [Quantitative Concept]
   760   C0220900:prevalence [Quantitative Concept]

Phrase: "in Turkey"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041400:Turkey [Geographic Area]
  1000   C0325628:Turkey, NOS [Bird]
  1000   C2348826:TURKEY [Food]

Phrase: "is"

Phrase: "particularly high at 0.83.7/1000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205250:High [Qualitative Concept]
   748   C1299351:High [Qualitative Concept]
   748   C2700149:HIGH [Intellectual Product]

Phrase: "[4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "]."
Processing 00000000.tx.28: Onset of the disease is usually in the third and fourth decade of life and the male to female sex ratio is approximately equal, although the disease often has a more severe course in males. 

Phrase: "Onset of the disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0277793:disease onset [Temporal Concept]
   770   C0332162:Onset [Qualitative Concept]

Phrase: "is"

Phrase: "usually in the third"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205437:Third [Quantitative Concept]

Phrase: "and"

Phrase: "fourth decade of life"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2981279:Decade [Quantitative Concept]

Phrase: "and"

Phrase: "the male to female sex ratio"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0024554:MALE SEX [Finding]
           Male
   753   C0086582:male [Population Group]
   753   C1706180:Male [Qualitative Concept]
   753   C1706428:Male [Qualitative Concept]
   753   C1706429:Male [Organism Attribute]

Phrase: "is"

Phrase: "approximately equal,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205163:Equal [Qualitative Concept]
   861   C1549782:Equal [Idea or Concept]

Phrase: "although"

Phrase: "the disease often"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "a more severe course in males."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1842211:Severe course [Finding]
   753   C0750729:Course [Temporal Concept]
Processing 00000000.tx.29: The cause of Behet's disease remains to be elucidated. 

Phrase: "The cause of Behet's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1314792:disease cause [Functional Concept]
   760   C0015127:cause [Functional Concept]
   760   C1524003:Cause [Conceptual Entity]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.30: Environmental factors including streptococcal and viral infection, directly or by cross-reacting with the heat shock proteins have been suggested as triggering factors. 

Phrase: "Environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "streptococcal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038402:Streptococcal [Bacterium]

Phrase: "and"

Phrase: "viral infection,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0042769:Viral infection [Disease or Syndrome]
   861   C0009450:Infection, NOS [Disease or Syndrome]
   861   C0521026:Viral [Functional Concept]
   789 E C0439663:Infected [Functional Concept]
   750 E C0030657:infectivity [Qualitative Concept]

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "or by"

Phrase: "cross-reacting with the heat shock proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0018850:Heat shock proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0282498:Heat Shock [Physiologic Function]
   748   C0018837:Heat [Natural Phenomenon or Process]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036974:Shock [Pathologic Function]
   748   C2828360:Cross [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "suggested as triggering factors."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   816   C0032930:triggering factor [Clinical Attribute]
           Trigger
   737   C1444748:Trigger [Qualitative Concept]
   737   C1521761:Factor [Functional Concept]
   737   C1705535:Suggest [Idea or Concept]
   737   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.31: Genetic factors are also implicated in the pathogenesis. 

Phrase: "Genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "are"

Phrase: "also"

Phrase: "implicated in the pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.32: There is a strong association with HLA-B51 [6, 7] and an increased incidence in close family members. 

Phrase: "There"

Phrase: "is"

Phrase: "a strong association with HLA-B51"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "[6,"

Phrase: "7"

Phrase: "]"

Phrase: "and"

Phrase: "an increased incidence in close family members."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021149:Incidence [Quantitative Concept]
   748   C0220856:incidence [Functional Concept]
Processing 00000000.tx.33: Gul et al. 

Phrase: "Gul et al."
Processing 00000000.tx.34: [8] have calculated a sibling risk ratio (s) of 11.452.5 in Turkish patients with Behet's disease. 

Phrase: "[8"

Phrase: "]"

Phrase: "have"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "a sibling risk ratio"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0028873:Risk Ratio [Quantitative Concept]
   901   C0242492:risk ratio [Quantitative Concept]
   827   C0035647:Risk [Qualitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "("

Phrase: "s) of 11.452.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2603362:S' [Clinical Attribute]

Phrase: "in Turkish patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.35: Immunological investigations have demonstrated the presence of immune dysregulation among Behet's disease patients [9]. 

Phrase: "Immunological investigations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261322:Investigations [Health Care Activity]
   827 E C1552578:investigation [Idea or Concept]
   777 E C1517586:Investigational [Qualitative Concept]
   777 E C3245491:investigational [Intellectual Product]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "the presence of immune dysregulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "among Behet's disease patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "[9"

Phrase: "]."
Processing 00000000.tx.36: Lymphocytes from patients with Behet's disease can generate supernatants with greater neutrophil-potentiating activity compared with control lymphocytes [10]. 

Phrase: "Lymphocytes from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0024264:Lymphocytes [Cell]

Phrase: "with Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "can"

Phrase: "generate"

Phrase: "supernatants with greater neutrophil-potentiating activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1550101:Supernatant [Body Substance]

Phrase: "compared with control lymphocytes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0024264:Lymphocytes [Cell]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "[10"

Phrase: "]."
Processing 00000000.tx.37: Chemotactic activity of polymorphonuclear leucocytes in patients with Behet's disease has also been reported to be increased [11]. 

Phrase: "Chemotactic activity of polymorphonuclear leucocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "[11"

Phrase: "]."
Processing 00000000.tx.38: Since cytokines are involved in the regulation of functions of lymphocytes and phagocytes, they may play an important role in the pathogenesis of Behet's disease [1215]. 

Phrase: "Since"

Phrase: "cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "involved in the regulation of functions of lymphocytes"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   744   C0024264:Lymphocytes [Cell]
   744   C0542341:Functions [Functional Concept]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1314939:Involved [Functional Concept]
   744   C1327622:Regulation [Biologic Function]
   734   C1518062:Lymphocyte Function [Biomedical Occupation or Discipline]
   711 E C0031843:function [Physiologic Function]
   711 E C0700205:FUNCTION [Classification]
   711 E C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "phagocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031307:Phagocytes [Cell]

Phrase: "they"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the pathogenesis of Behet's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "[1215"

Phrase: "]."
Processing 00000000.tx.39: The serum concentrations of mainly TH1-type cytokines have been reported to be increased in Behet's disease, including interleukin 1 (IL-1) [1315]. 

Phrase: "The serum concentrations of mainly TH1-type cytokines"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0683149:concentrations serum [Quantitative Concept]
   744   C0086045:Concentrations [Mental Process]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "increased in Behet's disease,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   773   C0277564:Acquired disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "interleukin 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(IL-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "[1315"

Phrase: "]."
Processing 00000000.tx.40: The IL-1 gene cluster on chromosome 2q12-q13 contains three related genes IL-1A, IL-1B and IL-1RN, encoding the pro-inflammatory cytokines IL-1, IL-1 and their endogenous receptor antagonist IL-1ra [16] (Fig. 1). 

Phrase: "The IL-1 gene cluster on chromosome 2q12-q13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0017258:Gene cluster [Gene or Genome]
   742   C1555715:Cluster [Idea or Concept]
   742   C1704332:Cluster [Quantitative Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "three related genes IL-1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450344:1A [Intellectual Product]
   804   C1553633:1a [Medical Device]

Phrase: "IL-1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "IL-1RN,"

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the pro-inflammatory cytokines IL-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "IL-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "their endogenous receptor antagonist IL-1ra"

Phrase: "[16"

Phrase: "]"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.41: IL-1 and IL-1 are potent pro-inflammatory cytokines and play a central role in many inflammatory cascades. 

Phrase: "IL-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IL-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "potent pro-inflammatory cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a central role in many inflammatory cascades."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.42: They also activate endothelial cells, and among other things, induce the expression of adhesion molecules that mediate the attachment and transendothelial migration of leucocytes at inflammatory sites [1720]. 

Phrase: "They also"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and among other things,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515981:And [Idea or Concept]
   737   C1551338:Thing [Entity]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of adhesion molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the attachment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185023:Attachment [Therapeutic or Preventive Procedure]
  1000   C1947904:Attachment [Activity]
  1000   C1999228:Attachment [Intellectual Product]

Phrase: "and"

Phrase: "transendothelial migration of leucocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2936223:Transendothelial Migration [Organ or Tissue Function]
   802   C1326500:leucocyte migration [Cell Function]
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "at inflammatory sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "[1720"

Phrase: "]."
Processing 00000000.tx.43: View larger version (14K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.44: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.45: The polymorphic loci in the IL-1 gene cluster with approximate physical distances.  

Phrase: "The polymorphic loci in the IL-1 gene cluster"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C1708726:Gene Locus [Gene or Genome]
           Locus

Phrase: "with approximate physical distances."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0012751:distances [Quantitative Concept]
   743 E C0443203:Distant [Spatial Concept]
Processing 00000000.tx.46: Given the involvement of IL-1 in Behet's disease, the aim of this study was to investigate the possibility that inheritance of specific polymorphisms of IL-1A, IL-1B and IL-1RN genes might be associated with increased susceptibility to Behet's disease.  

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the involvement of IL-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in Behet's disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "the aim of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1947946:Aim [Idea or Concept]
   760   C2948600:Aim [Pharmacologic Substance]
   760   C3540471:AIM [Gene or Genome]
   760   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the possibility"

Phrase: "that inheritance of specific polymorphisms of IL-1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0242538:Inheritance [Quantitative Concept]
   744   C0728826:Inheritance [Functional Concept]

Phrase: "IL-1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "IL-1RN genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C1334205:Interleukin Gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "might"

Phrase: "be"

Phrase: "associated with increased susceptibility"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0205217:Increased [Quantitative Concept]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C0442805:Increased [Functional Concept]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "to Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.47: Patients and methods Top Abstract Introduction Patients and methods Results Discussion References  Patients EDTA-anticoagulated blood samples were obtained from 132 unrelated Behet's disease patients (82 male and 50 female) of Turkish origin, in compliance with the principles of the Declaration of Helsinki. 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Patients EDTA-anticoagulated blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0178913:blood samples [Body Substance]
   771   C0370003:Sample [Substance]
   771   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "obtained from 132 unrelated Behet's disease patients"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0012634:Disease [Disease or Syndrome]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0445356:Unrelated [Finding]
   748   C1301820:Obtained [Functional Concept]
   748   C1704623:Unrelated [Qualitative Concept]
   728   C0277564:Acquired disease [Disease or Syndrome]
   714 E C1706701:Obtain [Activity]

Phrase: "(82 male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "50 female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015780:Female [Finding]
   861   C0043210:female [Population Group]
   861   C0086287:female [Population Group]
   861   C1705497:Female [Qualitative Concept]
   861   C1705498:Female [Qualitative Concept]

Phrase: ")"

Phrase: "of Turkish origin,"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   861   C0079946:origin [Classification]
   861   C0439659:Origin [Temporal Concept]
   861   C1550512:origin [Intellectual Product]
   805 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   805 E C0314603:Genetic [Functional Concept]
   789 E C0205313:Original [Idea or Concept]
   789 E C2347409:Original [Occupational Activity]
   777 E C0005615:Birth [Organism Function]
   777 E C0035150:Reproduction [Organism Function]
   777 E C1550722:birth [Idea or Concept]
   777 E C3245487:birth [Intellectual Product]
   761 E C0454729:Natal [Geographic Area]
   761 E C0559522:Genital [Body System]
   761 E C0598240:originality [Mental Process]
   761 E C1546649:Genital [Intellectual Product]
   761 E C1550642:Genital [Body Substance]

Phrase: "in compliance with the principles"

Phrase: "of the Declaration"

Phrase: "of Helsinki."
Processing 00000000.tx.48: The diagnosis of Behet's disease met the criteria of the International Study Group in all cases [3]. 

Phrase: "The diagnosis of Behet's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011900:Diagnosis [Finding]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "the criteria of the International Study Group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243161:criteria [Intellectual Product]

Phrase: "in all cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "[3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "]."
Processing 00000000.tx.49: Ethnically matched 106 healthy volunteers (61 male, 44 female) who had no Behet's disease-related manifestations, including recurrent aphthous stomatitis or a family history for Behet's disease, comprised the control group. 

Phrase: "Ethnically"

Phrase: "matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:matched [Research Activity]
  1000   C1708943:Matched [Qualitative Concept]

Phrase: "106 healthy volunteers"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C1708335:Healthy Volunteers [Population Group]
   827   C0042960:Volunteers [Professional or Occupational Group]
   793 E C1549078:Volunteer [Idea or Concept]
   793 E C1997894:volunteer [Population Group]

Phrase: "(61 male,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]

Phrase: "44 female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015780:Female [Finding]
   861   C0043210:female [Population Group]
   861   C0086287:female [Population Group]
   861   C1705497:Female [Qualitative Concept]
   861   C1705498:Female [Qualitative Concept]

Phrase: ")"

Phrase: "who"

Phrase: "had"

Phrase: "no Behet's disease-related manifestations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205319:manifestations [Functional Concept]
   812   C1280464:manifestations [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "recurrent aphthous stomatitis"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0585213:recurrent aphthous stomatitis [Disease or Syndrome]
           aphthous stomatitis
  1000   C2931748:Aphthous Stomatitis, Recurrent [Disease or Syndrome]
  1000   C2937365:Recurrent aphthous stomatitis [Disease or Syndrome]
   901   C0038363:Aphthous Stomatitis [Disease or Syndrome]
   827   C0038362:Stomatitis [Disease or Syndrome]
   827   C2945760:Recurrent [Temporal Concept]
   755 E C0034897:Recurrence [Phenomenon or Process]
   755 E C1458156:recurrence [Neoplastic Process]
   755 E C2825055:Recurrence [Pathologic Function]

Phrase: "or"

Phrase: "a family history for Behet's disease,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   820   C0850707:disease family history [Finding]
   790   C0241889:Family history [Finding]
   790   C1705495:Family History [Idea or Concept]
   783   C0344339:disease family [Finding]
   783   C0683519:disease history [Finding]
   753   C0015576:Family [Family Group]
   753   C0019664:History [Occupation or Discipline]
   753   C0019665:history [Intellectual Product]
   753   C0262512:History, NOS [Organism Attribute]
   753   C0262926:History [Finding]
   753   C1704727:Family [Conceptual Entity]
   753   C1705255:History [Conceptual Entity]
   753   C2004062:History [Finding]
   748 E C0277558:Familial disease [Disease or Syndrome]

Phrase: "comprised"

Phrase: "the control group."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.50: Genomic DNA was extracted from blood samples using the DNAce maxiblood purification system (Bioline, London, UK). 

Phrase: "Genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "extracted from blood samples"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0178913:blood samples [Body Substance]
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0229664:Blood [Body Substance]
   770   C3541890:EXTRACTED [Finding]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]
   737 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the DNAce maxiblood purification system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Bioline,"

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.51: Genotyping Genotypes for previously described IL-1A, IL-1B and IL-1RN gene polymorphisms were assigned to patients and controls. 

Phrase: "Genotyping Genotypes for previously described IL-1A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017431:Genotypes [Organism Attribute]

Phrase: "IL-1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "IL-1RN gene polymorphisms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0678951:gene polymorphisms [Genetic Function]
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]
   708   C1334205:Interleukin Gene [Gene or Genome]

Phrase: "were"

Phrase: "assigned to patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1516050:Assigned [Functional Concept]
   790   C1552601:assigned [Intellectual Product]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.52: These included single nucleotide polymorphisms of IL-1A -889 C/T [21], IL-1B -511 C/T [22], -35 T/C [23], +5810 G/A [23] and +5887 T/C [23] and IL-1RN +8006 T/C [23], +8061 C/T [23], +9589 A/T [23], +11100 T/C [23] and 86-bp variable number of tandem repeat (VNTR) polymorphism of IL-1RN [24]. 

Phrase: "These included single nucleotide polymorphisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "of IL-1A -889 C/T [21"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   895   C0962190:interleukin-21 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   895   C1416406:INTERLEUKIN 21 [Gene or Genome]
   799   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0450344:1A [Intellectual Product]
   799   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C1553633:1a [Medical Device]

Phrase: "],"

Phrase: "IL-1B -511 C/T [22"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   895   C0961814:interleukin-22 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   895   C1423038:INTERLEUKIN 22 [Gene or Genome]
   895   C2697771:Interleukin 22 [Laboratory Procedure]
   799   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0450345:1B [Intellectual Product]
   799   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "], -"

Phrase: "35 T/C [23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450348:23 [Quantitative Concept]

Phrase: "],"

Phrase: "+5810 G/A [23"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439267:g% [Quantitative Concept]
   812   C0450348:23 [Quantitative Concept]

Phrase: "]"

Phrase: "and +"

Phrase: "5887 T/C [23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450348:23 [Quantitative Concept]

Phrase: "]"

Phrase: "and"

Phrase: "IL-1RN +8006 T/C [23"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C0963088:interleukin-23 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   895   C1882965:Interleukin 23 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0450348:23 [Quantitative Concept]
   799   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "],"

Phrase: "+8061 C/T [23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450348:23 [Quantitative Concept]

Phrase: "],"

Phrase: "+9589 A/T [23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450348:23 [Quantitative Concept]

Phrase: "],"

Phrase: "+11100 T/C [23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450348:23 [Quantitative Concept]

Phrase: "]"

Phrase: "and"

Phrase: "86-bp variable number of tandem repeat (VNTR) polymorphism of IL-1RN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0242827:Variable Number Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1710347:Variable Number Tandem Repeat [Cell or Molecular Dysfunction]
   772   C3179163:Variable Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0237753:*Number [Quantitative Concept]
   738   C0439828:Variable [Qualitative Concept]
   738   C0449788:Number [Quantitative Concept]

Phrase: "[24"

Phrase: "]."
Processing 00000000.tx.53: DNA (100150 ng) was amplified by polymerase chain reaction (PCR) using the forward and reverse oligonucleotide primers described in the references given above. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(100150 ng)"

Phrase: "was"

Phrase: "amplified by polymerase chain reaction (PCR)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "and"

Phrase: "reverse oligonucleotide primers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer
   896   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]

Phrase: "described in the references"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1552738:described [Idea or Concept]
   737   C1514811:Reference [Idea or Concept]
   737   C1706462:Reference [Conceptual Entity]

Phrase: "given above."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1442162:GIVEN [Conceptual Entity]
   833   C1550718:given [Idea or Concept]
   833   C3244317:given [Intellectual Product]
   799 E C1947971:Give [Functional Concept]
Processing 00000000.tx.54: PCR reactions for IL-1A, IL-1B and IL-1RN were performed in 25-l volumes using 1x KCl or 1x NH4 buffer with optimized MgCl2 concentration, 100 M dNTPs, 6 pmol primers, 1U Taq polymerase (Bioline), and for some reactions 1x 4% betain or 1x 50% glycerol were added. 

Phrase: "PCR reactions for IL-1A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0032520:Reactions, Polymerase Chain [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "IL-1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "IL-1RN"

Phrase: "were"

Phrase: "performed in 25-l volumes"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0449468:volumes [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   726 E C1690016:% volume [Qualitative Concept]
   726 E C1705102:Volume [Intellectual Product]
   726 E C2700258:Volume [Laboratory Procedure]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1x KCl"

Phrase: "or"

Phrase: "1x NH4 buffer with optimized MgCl2 concentration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "100 M dNTPs,"

Phrase: "6 pmol primers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "1U Taq polymerase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0075813:Taq Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Bioline"

Phrase: ")"

Phrase: ","

Phrase: "and for some reactions 1x 4% betain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1515981:And [Idea or Concept]
   714   C0443286:Reaction [Functional Concept]
   714   C1114821:Reaction [Clinical Attribute]

Phrase: "or"

Phrase: "1x 50% glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.55: Amplifications were performed using a Hybaid Omnigene Thermal Cycler (Teddington Middlesex, UK) at the relevant annealing temperature and for 35 cycles. 

Phrase: "Amplifications"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1517480:Amplification [Molecular Biology Research Technique]
   966   C1521871:Amplification [Phenomenon or Process]
   966   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Hybaid Omnigene Thermal Cycler"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1611676:Thermal Cycler [Medical Device]

Phrase: "(Teddington Middlesex,"

Phrase: "UK"

Phrase: ")"

Phrase: "at the relevant annealing temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]

Phrase: "and for 35 cycles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515981:And [Idea or Concept]
   737   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.56: Genotypes were assigned by restriction enzyme digestion of the PCR products. 

Phrase: "Genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "assigned by restriction enzyme digestion of the PCR products."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   775   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   756   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0012238:Digestion [Organism Function]
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0337112:Chain [Manufactured Object]
   738   C0443286:Reaction [Functional Concept]
   738   C0443288:Restriction [Functional Concept]
   738   C1114821:Reaction [Clinical Attribute]
   738   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1514468:Products [Entity]
   738   C1516050:Assigned [Functional Concept]
   738   C1524075:Chain [Idea or Concept]
   738   C1552601:assigned [Intellectual Product]
   738   C2349986:Digestion [Research Activity]
   704 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.57: Each product was digested with 4 U of the appropriate restriction enzyme in a 15-l volume overnight. 

Phrase: "Each product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "digested with 4 U of the appropriate restriction enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1880519:{Enzyme}U [Quantitative Concept]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0443288:Restriction [Functional Concept]
   742   C0868946:digested [Physiologic Function]
   742   C1548787:Appropriate [Qualitative Concept]

Phrase: "in a 15-l volume overnight."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0449468:*Volume [Quantitative Concept]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.58: PCR-digested products were run out by electrophoresis on a 3% agarose gel stained with ethidium bromide and visualized under UV light. 

Phrase: "PCR-digested products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "out by electrophoresis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "on a 3% agarose gel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1706746:Agarose Gel [Research Device]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]

Phrase: "stained with ethidium bromide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   770   C0006222:Bromide [Inorganic Chemical]
   770   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "visualized under UV light."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0041625:UV Light [Natural Phenomenon or Process]
           UV
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C0234621:Visualized [Functional Concept]
   770   C1306462:Light [Functional Concept]
   770   C1881376:Light [Qualitative Concept]
   770   C1961129:uV [Quantitative Concept]
Processing 00000000.tx.59: PCR products for the IL-1RN 86-bp VNTR were run directly on 2% agarose gels. 

Phrase: "PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "for the IL-1RN 86-bp VNTR"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   835   C0242827:Variable Number Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   835   C1710347:Variable Number Tandem Repeat [Cell or Molecular Dysfunction]
   832   C3179163:Variable Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   801   C0039290:Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   788   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   788   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   788   C0205341:Repeat [Functional Concept]
   788   C0237753:*Number [Quantitative Concept]
   788   C0439828:Variable [Qualitative Concept]
   788   C0449788:Number [Quantitative Concept]
   788   C0521125:For [Qualitative Concept]
   788   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   788   C1547730:Repeat [Temporal Concept]
   788   C1705914:Repeat [Conceptual Entity]

Phrase: "were"

Phrase: "run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "directly on 2% agarose gels."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1706746:Agarose Gel [Research Device]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C1947931:Directly [Qualitative Concept]
   726 E C1382104:Gel [Substance]
Processing 00000000.tx.60: Statistical analysis Each polymorphism was examined in the control population to confirm that the distribution of the genotypes conformed to HardyWeinberg expectations. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "Each polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "examined in the control population to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0032662:control population [Occupation or Discipline]
   753   C0032659:Population [Quantitative Concept]
   753   C0243148:control [Qualitative Concept]
   753   C0332128:Examined [Finding]
   753   C1257890:Population [Population Group]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the distribution of the genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "conformed to HardyWeinberg expectations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0679138:Expectations [Idea or Concept]
Processing 00000000.tx.61: The distribution of alleles and genotypes for each polymorphism was compared between cases and controls using a 2-test. 

Phrase: "The distribution of alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "genotypes for each polymorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotypes [Organism Attribute]

Phrase: "was"

Phrase: "compared between cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0868928:Cases [Functional Concept]
   790   C1533148:Cases [Quantitative Concept]
   790   C1707455:Compared [Activity]
   756 E C1706255:CASE [Medical Device]
   756 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 2-test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
Processing 00000000.tx.62: The Estimated haplotype (EH) program [25] was used to calculate the linkage disequilibrium between the polymorphic sites, and the EH and Phase [26] programs were used to reconstruct haplotypes. 

Phrase: "The Estimated haplotype (EH) program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]

Phrase: "[25"

Phrase: "]"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "the linkage disequilibrium between the polymorphic sites,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0023746:Linkage Disequilibrium [Quantitative Concept]
   748   C0023745:linkage [Molecular Function]
   748   C0281825:Disequilibrium [Finding]
   748   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "the EH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "and"

Phrase: "Phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205390:Phase [Temporal Concept]

Phrase: "[26"

Phrase: "] programs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0376691:Programs [Intellectual Product]
  1000   C3484370:Programs [Functional Concept]
   966 E C1709697:Program [Conceptual Entity]
   966 E C2728259:Program [Pharmacologic Substance]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reconstruct"

Phrase: "haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.63: Odds ratios (OR) and 95% confidence intervals (CI) were calculated to assess the risk associated with particular alleles, genotypes or haplotypes. 

Phrase: "Odds ratios (OR)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "95% confidence intervals (CI)"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "associated with particular alleles,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0002085:Alleles [Gene or Genome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "or"

Phrase: "haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.64: Calculations were performed using Stata version 6 (Stata Corporation, USA).  

Phrase: "Calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1441506:Calculation [Activity]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Stata version 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: "(Stata Corporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corporation [Organization]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.65: Results Top Abstract Introduction Patients and methods Results Discussion References  The distribution of IL-1A -889 alleles and genotype frequencies were significantly different between cases and controls. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The distribution of IL-1A -889 alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "genotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "significantly different between cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.66: This was reflected by an increase in both the -889C allele and CC genotype frequencies in patients with Behet's disease compared with controls (76.6 vs 42.9%, OR=1.7, P=0.01, and 76 vs 45%, OR=1.95, P=0.012, respectively) (Table 1). 

Phrase: "This"

Phrase: "was"

Phrase: "reflected by an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C0558058:reflected [Mental Process]

Phrase: "in both"

Phrase: "the -889C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "CC genotype frequencies in patients"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "with Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(76.6"

Phrase: "vs"

Phrase: "42.9%,"

Phrase: "OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=1.7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "P=0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "76"

Phrase: "vs"

Phrase: "45%,"

Phrase: "OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=1.95,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "P=0.012,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450301:0.012" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.67: View this table: [in this window] [in a new window]  TABLE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.68: Allele and genotype frequencies of IL-1A gene -889*C/T polymorphism in patients with Behet's disease and controls  In the IL-1B gene, there was a specific increase in both +5887T allele and TT genotype frequencies in cases vs controls (83.5 vs 76.2%, OR=1.6, P=0.05, and 92 vs 60%, OR=1.8, P=0.03, respectively) (Table 2). 

Phrase: "Allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "genotype frequencies of IL-1A gene -889"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   774   C0017270:Gene Frequencies [Quantitative Concept]
   748   C0439603:Frequencies [Temporal Concept]
   714 E C0376249:frequency [Quantitative Concept]
   714 E C0871396:Frequency [Quantitative Concept]
   714 E C1561548:Frequency [Qualitative Concept]
   714 E C1705502:Frequency [Quantitative Concept]

Phrase: "*C/T polymorphism in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032529:Polymorphism [Genetic Function]
   760   C1882417:Polymorphism [Qualitative Concept]

Phrase: "with Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "controls  In the IL-1B gene,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C1334205:Interleukin Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0243148:control [Qualitative Concept]
   753   C0450345:1B [Intellectual Product]
   753   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "there"

Phrase: "was"

Phrase: "a specific increase in both +5887T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "TT genotype frequencies in cases"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "vs"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(83.5"

Phrase: "vs"

Phrase: "76.2%,"

Phrase: "OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=1.6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "P=0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "92"

Phrase: "vs"

Phrase: "60%,"

Phrase: "OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=1.8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "P=0.03,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.69: View this table: [in this window] [in a new window]  TABLE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.70: IL-1B polymorphisms in Behet's disease patients (BD) and controls  Examination of other markers in the IL-1B and IL-1 RN genes revealed that the overall distribution of alleles and genotypes in patients with Behet's disease and controls were not significantly different (Tables 2 and 3). 

Phrase: "IL-1B polymorphisms in Behet's disease patients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0032529:polymorphisms [Genetic Function]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(BD)"

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Examination of other markers"

Phrase: "in the IL-1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "IL-1 RN genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   906   C1708431:Interleukin 1 Gene [Gene or Genome]
   886   C1334205:Interleukin Gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the overall distribution of alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "genotypes in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017431:Genotypes [Organism Attribute]

Phrase: "with Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "not significantly different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705242:Different [Qualitative Concept]
   755 E C1705241:*Difference [Quantitative Concept]
   727 E C0443199:Differential [Qualitative Concept]

Phrase: "(Tables 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.71: View this table: [in this window] [in a new window]  TABLE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.72: IL-1 receptor antagonist gene (IL-1 RN) single nucleotide and variable number of tandem repeat polymorphisms in Behet's disease (BD) patients and controls  As both the IL-1A -889C/-889C and IL-1B +5887T/+5887T genotypes were found to be individually associated with Behet's disease, we tested the possibility of linkage disequilibrium between the two polymorphic sites. 

Phrase: "IL-1 receptor antagonist gene"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1416402:Interleukin 1 Receptor Antagonist Gene [Gene or Genome]
           INTERLEUKIN 1 RECEPTOR ANTAGONIST
   911   C1708431:Interleukin 1 Gene [Gene or Genome]
   897   C1334205:Interleukin Gene [Gene or Genome]
   853   C1335671:Receptor Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   771   C1704264:interleukin-1 receptor antagonist [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   771   C3536785:Interleukin-1 Receptor Antagonist [Pharmacologic Substance]
   717   C0063710:Interleukin 1 Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C1416395:INTERLEUKIN 1 RECEPTOR [Gene or Genome]

Phrase: "(IL-1 RN) single nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "variable number of tandem repeat polymorphisms"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   858   C0242827:Variable Number Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   858   C1710347:Variable Number Tandem Repeat [Cell or Molecular Dysfunction]
   820   C3179163:Variable Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0237753:*Number [Quantitative Concept]
   753   C0439828:Variable [Qualitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "in Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(BD) patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "controls  As both"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "the IL-1A -889C/-889C"

Phrase: "and"

Phrase: "IL-1B +5887T/+5887T genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "individually"

Phrase: "associated with Behet's disease,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the possibility of linkage disequilibrium"

Phrase: "between the two polymorphic sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.73: The EH program revealed a D value of 0.79 suggesting the presence of linkage disequilibrium between IL-1A -889 and IL-1B +5887 (P < 0.0001) (data not shown for other polymorphic sites). 

Phrase: "The EH program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a D value of 0.79"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of linkage disequilibrium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "between IL-1A -889"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0450344:1A [Intellectual Product]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "IL-1B +5887"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0450345:1B [Intellectual Product]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown for other polymorphic sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205145:Sites [Spatial Concept]
   760   C1882417:Polymorphic [Qualitative Concept]
   726 E C1515974:Site [Body Location or Region]
   726   C1547282:Show [Intellectual Product]
   726 E C2825164:Site [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.74: The frequencies of the reconstructed IL-1A -889 and IL-1B +5887 haplotypes using both the EH and Phase software packages are given in Table 4. 

Phrase: "The frequencies of the reconstructed IL-1A -889"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   744   C0439603:Frequencies [Temporal Concept]
   711 E C0376249:frequency [Quantitative Concept]
   711 E C0871396:Frequency [Quantitative Concept]
   711 E C1561548:Frequency [Qualitative Concept]
   711 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "IL-1B +5887 haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotypes [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both the EH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "and"

Phrase: "Phase software packages"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0013194:Package [Medical Device]
   793   C2700580:Package [Manufactured Object]

Phrase: "are"

Phrase: "given in Table 4."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3244317:given [Intellectual Product]
   737 E C1947971:Give [Functional Concept]
Processing 00000000.tx.75: The IL-1A -889C/ IL-1B +5887T haplotype was inherited more often in cases than controls. 

Phrase: "The IL-1A -889C/ IL-1B +5887T haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0018591:Haplotype [Organism Attribute]

Phrase: "was"

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "more often in cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205172:More [Functional Concept]
   770   C0332183:Often [Temporal Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "than controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.76: When the inheritance of combined IL-1A -889C/-889C and IL-1B +5887T/+5887T genotype (CC/TT) was compared with inheritance of any other IL-1A -889/ IL-1B 5887 genotypes, there was a significant difference between cases and controls. 

Phrase: "When"

Phrase: "the inheritance of combined IL-1A -889C/-889C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0242538:Inheritance [Quantitative Concept]
   744   C0728826:Inheritance [Functional Concept]

Phrase: "and"

Phrase: "IL-1B +5887T/+5887T genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017431:Genotype [Organism Attribute]

Phrase: "(CC/TT)"

Phrase: "was"

Phrase: "compared with inheritance of any"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242538:Inheritance [Quantitative Concept]
   760   C0728826:Inheritance [Functional Concept]
   760   C1707455:Compared [Activity]

Phrase: "other IL-1A -889/ IL-1B 5887 genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0017431:Genotypes [Organism Attribute]

Phrase: "there"

Phrase: "was"

Phrase: "a significant difference between cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.77: Of 127 cases, 73 had the CC/TT genotype compared with only 40 of 105 controls (OR=2.2, CI=1.33.7, P=0.003). 

Phrase: "Of 127 cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "73"

Phrase: "had"

Phrase: "the CC/TT genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "compared with only 40 of 105 controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0205171:Only [Quantitative Concept]
   748   C0439509:/40 [Temporal Concept]
   748   C1707455:Compared [Activity]
   748   C1720467:Only [Intellectual Product]
   714   C0243148:control [Qualitative Concept]
   714   C1550141:Control [Substance]
   714   C1882979:Control [Conceptual Entity]
   714   C2587213:Control [Functional Concept]
   714   C3274648:Control [Qualitative Concept]

Phrase: "(OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=2.2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "CI"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0009667:Confidence Intervals [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:intervals [Temporal Concept]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   827 E C1552654:Interval [Idea or Concept]
   827 E C1552713:Interval [Intellectual Product]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: "=1.33.7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C3541329:1-7 [Gene or Genome]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "P=0.003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.78: View this table: [in this window] [in a new window]  TABLE 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.79: The frequencies of IL-1A -889 and IL-1B +5887 haplotypes reconstructed using the EH and Phase programs   Discussion Top Abstract Introduction Patients and methods Results Discussion References  Although the aetiology of Behet's disease is not yet known, genetic predisposition and immune dysregulation seem to be important factors in the pathogenesis. 

Phrase: "The frequencies of IL-1A -889"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "IL-1B +5887 haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotypes [Organism Attribute]

Phrase: "reconstructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348043:Reconstructed [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the EH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "and"

Phrase: "Phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205390:Phase [Temporal Concept]

Phrase: "programs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0376691:Programs [Intellectual Product]
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "Discussion Top Abstract Introduction Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Results Discussion References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Although"

Phrase: "the aetiology of Behet's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1314792:disease etiology [Functional Concept]
           Aetiology
   760   C0015127:aetiology [Functional Concept]
   760   C1524003:Etiology [Conceptual Entity]

Phrase: "is"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "genetic predisposition"
Meta Candidates (Total=20; Excluded=15; Pruned=0; Remaining=5)
  1000   C0314657:Genetic Predisposition [Organism Attribute]
   861   C0012655:Predisposition [Clinical Attribute]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0220898:Predisposition [Organism Attribute]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   789 E C0231203:Predisposed [Functional Concept]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "immune dysregulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1844666:Immune dysregulation [Finding]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important factors in the pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.80: Serum levels of pro-inflammatory and TH1-type cytokines, including IL-1, have been reported to be elevated in Behet's disease [1215]. 

Phrase: "Serum levels of pro-inflammatory"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0229671:Serum [Body Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "TH1-type cytokines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "IL-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elevated in Behet's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205250:Elevated [Qualitative Concept]
   770   C3163633:Elevated [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "[1215"

Phrase: "]."
Processing 00000000.tx.81: In addition, peripheral blood monocytes from patients with Behet's disease produce significantly more IL-1 when stimulated with bacterial lipopolysaccharide than monocytes from normal controls or from patients with other inflammatory diseases [12, 27]. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "peripheral blood monocytes from patients"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   828   C1321301:Peripheral blood monocyte [Cell]
   806   C0026473:blood monocytes [Cell]
           Monocytes
   806   C0229664:peripheral blood [Body Substance]
           Blood
   765 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0205100:Peripheral [Spatial Concept]

Phrase: "with Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "produce"

Phrase: "significantly more IL-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "when"

Phrase: "stimulated with bacterial lipopolysaccharide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023810:Lipopolysaccharide [Lipid]
   770   C0521009:Bacterial [Qualitative Concept]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "than monocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026473:Monocytes [Cell]

Phrase: "from normal controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   966   C2705716:normal control [Qualitative Concept]
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "or from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "with other inflammatory diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1290884:Inflammatory disease [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "[12,"

Phrase: "27"

Phrase: "]."
Processing 00000000.tx.82: Hence, we have hypothesized that increased IL-1 production in Behet's disease could be due to functional polymorphisms encoding differential gene regulation and expression. 

Phrase: "Hence,"

Phrase: "we"

Phrase: "have"

Phrase: "hypothesized"

Phrase: "that increased IL-1 production in Behet's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1819436:interleukin-1 production [Organism Function]
   767   C3159141:interleukin production [Organism Function]
   744   C0033268:production [Occupational Activity]

Phrase: "could"

Phrase: "be due to functional polymorphisms"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0032529:polymorphisms [Genetic Function]
   760   C0205245:Functional [Functional Concept]
   760   C0542341:Functional [Functional Concept]
   760   C2700217:Functional [Conceptual Entity]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "differential gene regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017263:Gene Regulation [Genetic Function]
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.83: This study demonstrates a significant association between the IL-1A -889 polymorphism and Behet's disease. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrates"

Phrase: "a significant association between the IL-1A -889 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.84: This polymorphism lies upstream in the 5' regulatory region in a sequence involved in transcriptional silencing of the IL-1A gene [21]. 

Phrase: "This polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "lies"

Phrase: "upstream in the 5' regulatory region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1883644:Upstream Region [Nucleotide Sequence]
   753   C0522505:Upstream [Spatial Concept]

Phrase: "in a sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "involved in transcriptional silencing of the IL-1A gene"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   781   C1156212:transcriptional gene silencing [Genetic Function]
   762   C0598496:Gene Silencing [Genetic Function]
   762   C1334205:Interleukin Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0040649:Transcriptional [Genetic Function]
           Gene Transcription
   742   C0450344:1A [Intellectual Product]
   742   C1314939:Involved [Functional Concept]
   742   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C1553633:1a [Medical Device]
   708   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "[21"

Phrase: "]."
Processing 00000000.tx.85: The IL-1A -889 polymorphism has been reported to be associated with a number of inflammatory diseases including juvenile rheumatoid arthritis [21] and Alzheimer's disease [28]. 

Phrase: "The IL-1A -889 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with a number of inflammatory diseases"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   762   C1290884:Inflammatory disease [Disease or Syndrome]
   757   C0243083:associated disease [Pathologic Function]
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0237753:*Number [Quantitative Concept]
   748   C0333348:Inflammatory [Functional Concept]
   748   C0449788:Number [Quantitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "juvenile rheumatoid arthritis"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3495559:Arthritis, Juvenile Rheumatoid [Disease or Syndrome]
           Juvenile arthritis
   901   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   901   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   867 E C0268113:Juvenile gout [Congenital Abnormality,Disease or Syndrome]
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C3146221:Juvenile [Age Group]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: "[21"

Phrase: "]"

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "[28"

Phrase: "]."
Processing 00000000.tx.86: However, in both studies the disease was associated with increased frequency of the IL-1A -889T allele. 

Phrase: "However,"

Phrase: "in both"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "associated with increased frequency of the IL-1A -889T allele."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   757   C0017270:Allele Frequency [Quantitative Concept]
   739   C0002085:Allele [Gene or Genome]
   739   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0205217:Increased [Quantitative Concept]
   739   C0376249:frequency [Quantitative Concept]
   739   C0439603:Frequency [Temporal Concept]
   739   C0442805:Increased [Functional Concept]
   739   C0450344:1A [Intellectual Product]
   739   C0871396:Frequency [Quantitative Concept]
   739   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C1553633:1a [Medical Device]
   739   C1561548:Frequency [Qualitative Concept]
   739   C1705502:Frequency [Quantitative Concept]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.87: In contrast, we found an increase in the -889C allele and CC genotype in patients with Behet's disease compared with controls. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "an increase in the -889C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "CC genotype in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotype [Organism Attribute]

Phrase: "with Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.88: One possible explanation is that the over-representation of the -889C allele could be secondary to another functional polymorphism associated with Behet's disease that is in linkage disequilibrium with the -889C allele. 

Phrase: "One possible explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that"

Phrase: "the over-representation of the -889C allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514861:Representation [Conceptual Entity]
   748   C1882932:Representation [Activity]

Phrase: "could"

Phrase: "be"

Phrase: "secondary to another functional polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0175668:Secondary to [Temporal Concept]
           Secondary
   760   C0027627:secondary [Neoplastic Process]
   760   C0205436:Secondary [Quantitative Concept]

Phrase: "associated with Behet's disease"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "that"

Phrase: "is in linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "with the -889C allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.89: This putative polymorphism in linkage disequilibrium with the C, but not with the T allele, might be specific to Behet's disease. 

Phrase: "This putative polymorphism in linkage disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032529:Polymorphism [Genetic Function]
   753   C1882417:Polymorphism [Qualitative Concept]

Phrase: "with the C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "but"

Phrase: "not with the T allele,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0002085:Allele [Gene or Genome]
   760   C1518422:Not [Functional Concept]

Phrase: "might"

Phrase: "be"

Phrase: "specific to Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.90: Alternatively, this linked putative polymorphism might be the same one as in juvenile rheumatoid arthritis or Alzheimer's disease, but it might be in linkage disequilibrium with different IL-1A -889 alleles in different populations. 

Phrase: "Alternatively,"

Phrase: "this linked putative polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "the same one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "as in juvenile rheumatoid arthritis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C3495559:Arthritis, Juvenile Rheumatoid [Disease or Syndrome]
           Juvenile arthritis
   806   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   806   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   760   C0003864:Arthritis [Disease or Syndrome]
   760   C3146221:Juvenile [Age Group]
   751 E C0268113:Juvenile gout [Congenital Abnormality,Disease or Syndrome]

Phrase: "or"

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "but"

Phrase: "it"

Phrase: "might"

Phrase: "be in linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C2987476:Be [Conceptual Entity]

Phrase: "with different IL-1A -889 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0002085:Alleles [Gene or Genome]

Phrase: "in different populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.91: Although, a GT polymorphism at position +4845 of the IL-1A gene has been reported to be in linkage disequilibrium with the -889 polymorphism, this polymorphism causes a conservative amino acid substitution (alanine to serine) at position 114, without any known functional significance [29]. 

Phrase: "Although"

Phrase: ","

Phrase: "a GT polymorphism at position +4845 of the IL-1A gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0678951:gene polymorphism [Genetic Function]
   738   C0032529:Polymorphism [Genetic Function]
   738   C1882417:Polymorphism [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be in linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C2987476:Be [Conceptual Entity]

Phrase: "with the -889 polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "this polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a conservative amino acid substitution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0525038:Amino Acid Substitution [Genetic Function,Molecular Biology Research Technique]
   812   C1555721:Substitution [Idea or Concept]
   812   C1706204:Substitution [Activity]

Phrase: "(alanine to serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "at position 114,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "without any known functional significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0237881:Significance [Quantitative Concept]
   827   C0750502:Significance [Idea or Concept]
   755 E C1546944:Significant [Qualitative Concept]

Phrase: "[29"

Phrase: "]."
Processing 00000000.tx.92: Hence, a putative functional polymorphism in linkage disequilibrium with IL-1A -889 has yet to be identified. 

Phrase: "Hence,"

Phrase: "a putative functional polymorphism in linkage disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "with IL-1A -889"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0450344:1A [Intellectual Product]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C1553633:1a [Medical Device]

Phrase: "has"

Phrase: "yet to"

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.93: Of four single nucleotide polymorphisms within the IL-1B gene investigated, only the +5887 polymorphism was found to be associated with Behet's disease. 

Phrase: "Of four single nucleotide polymorphisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "within the IL-1B gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1334205:Interleukin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: ","

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the +5887 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with Behet's disease."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.94: In previous studies the IL-1B +5887 polymorphism has been associated with a number of inflammatory conditions such as ulcerative colitis [30] and diabetic nephropathy [31], where the +5887T allele was increased in patients compared with controls. 

Phrase: "In previous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Previous [Temporal Concept]
  1000   C1552607:previous [Temporal Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "the IL-1B +5887 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "associated with a number of inflammatory conditions"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0243082:associated conditions [Pathologic Function]
   748   C0237753:*Number [Quantitative Concept]
   748   C0333348:Inflammatory [Functional Concept]
   748   C0449788:Number [Quantitative Concept]
   714   C0012634:condition [Disease or Syndrome]
   714   C0348080:Condition [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714   C1705253:Condition [Conceptual Entity]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "such as ulcerative colitis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009324:Ulcerative Colitis [Disease or Syndrome]
   861   C0009319:Colitis [Disease or Syndrome]
   861   C0041582:Ulcerative [Pathologic Function]
   861   C1963084:Colitis [Finding]

Phrase: "[30"

Phrase: "]"

Phrase: "and"

Phrase: "diabetic nephropathy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011881:Diabetic Nephropathy [Disease or Syndrome]
  1000   C1442864:diabetic nephropathy [Gene or Genome]
   861   C0022658:Nephropathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]

Phrase: "[31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "],"

Phrase: "where"

Phrase: "the +5887T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "increased in patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.95: In this study, there was no significant difference in the overall distribution of genotype frequencies for the IL-1B +5887 polymorphism in patients with Behet's disease. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference in the overall distribution of genotype frequencies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "for the IL-1B +5887 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.96: However, there was a significant increase in the specific frequency of the IL-1B +5887T allele and (TT) genotype in Behet's disease patients compared with controls. 

Phrase: "However,"

Phrase: "there"

Phrase: "was"

Phrase: "a significant increase in the specific frequency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "of the IL-1B +5887T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "and ("

Phrase: "TT) genotype in Behet's disease patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017431:Genotype [Organism Attribute]

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.97: Although this polymorphism occurs in exon 5 of the gene and represents a conservative substitution, it has been reported that the allele dosage of T at +5887 is directly related to IL-1 expression with yet unknown mechanisms, i.e. 

Phrase: "Although"

Phrase: "this polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "occurs in exon 5 of the gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0017337:Gene [Gene or Genome]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a conservative substitution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1555721:Substitution [Idea or Concept]
   861   C1706204:Substitution [Activity]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the allele dosage of T at +5887"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0178602:Dosage [Quantitative Concept]

Phrase: "is"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "related to IL-1 expression"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "with yet unknown mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.98: TT>CT>CC [32]. 

Phrase: "TT>CT>CC [32"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C3538933:CC [Cell Component]
   812   C3540513:CT [Gene or Genome]

Phrase: "]."
Processing 00000000.tx.99: The combined risk of carrying both homozygous IL-1A -889CC and IL-1B +5889TT genotypes (OR=2.2, CI=1.33.7) was higher than the individual risks of having one copy of IL-1A -889C (OR=1.7, CI 1.12.5) and IL-1B +5889T (OR=1.6, CI 1.02.5) or IL-1A -889CC (OR=1.95, CI 1.23.3) and IL-1B +5889TT (OR=1.8, CI 1.13.1) genotypes. 

Phrase: "The combined risk of carrying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "both homozygous IL-1A -889CC"

Phrase: "and"

Phrase: "IL-1B +5889TT genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "(OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=2.2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "CI"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0009667:Confidence Intervals [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:intervals [Temporal Concept]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   827 E C1552654:Interval [Idea or Concept]
   827 E C1552713:Interval [Intellectual Product]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: "=1.33.7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C3541329:1-7 [Gene or Genome]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "higher than the individual risks of"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   798   C0332167:High risk of [Qualitative Concept]
           high risks
   750 E C3272283:High Risk [Finding]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "having"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "copy of IL-1A -889C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0450344:1A [Intellectual Product]
   760   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1553633:1a [Medical Device]
   760   C1948062:Copy [Manufactured Object]

Phrase: "(OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=1.7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "CI 1.12.5"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   840   C0009667:Confidence Intervals [Quantitative Concept]
   804   C0237529:Confidence [Mental Process]
   804   C1272706:intervals [Temporal Concept]
   804   C1704725:Confidence [Qualitative Concept]
   804   C1704726:Confidence [Mental Process]
   771 E C1552654:Interval [Idea or Concept]
   771 E C1552713:Interval [Intellectual Product]
   733 E C0558095:Confident [Individual Behavior]
   704 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "IL-1B +5889T"

Phrase: "(OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=1.6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "CI 1.02.5"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   840   C0009667:Confidence Intervals [Quantitative Concept]
   804   C0237529:Confidence [Mental Process]
   804   C1272706:intervals [Temporal Concept]
   804   C1704725:Confidence [Qualitative Concept]
   804   C1704726:Confidence [Mental Process]
   771 E C1552654:Interval [Idea or Concept]
   771 E C1552713:Interval [Intellectual Product]
   733 E C0558095:Confident [Individual Behavior]
   704 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "IL-1A -889CC"

Phrase: "(OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=1.95,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "CI 1.23.3"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   840   C0009667:Confidence Intervals [Quantitative Concept]
   804   C0237529:Confidence [Mental Process]
   804   C0450348:23 [Quantitative Concept]
   804   C1272706:intervals [Temporal Concept]
   804   C1704725:Confidence [Qualitative Concept]
   804   C1704726:Confidence [Mental Process]
   771 E C1552654:Interval [Idea or Concept]
   771 E C1552713:Interval [Intellectual Product]
   733 E C0558095:Confident [Individual Behavior]
   704 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "IL-1B +5889TT"

Phrase: "(OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=1.8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "CI 1.13.1"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   840   C0009667:Confidence Intervals [Quantitative Concept]
   804   C0237529:Confidence [Mental Process]
   804   C1272706:intervals [Temporal Concept]
   804   C1704725:Confidence [Qualitative Concept]
   804   C1704726:Confidence [Mental Process]
   771 E C1552654:Interval [Idea or Concept]
   771 E C1552713:Interval [Intellectual Product]
   733 E C0558095:Confident [Individual Behavior]
   704 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: "genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.100: The functional consequences of these IL-1 polymorphisms are not yet known, and the putative functional polymorphic site on the IL-1A -889C/IL-1B +5889T haplotype and the characteristics of its biological effects remains to be elucidated. 

Phrase: "The functional consequences of these IL-1 polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "are"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "the putative functional polymorphic site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "on the IL-1A -889C/IL-1B +5889T haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0018591:Haplotype [Organism Attribute]

Phrase: "and"

Phrase: "the characteristics of its biological effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0005510:Characteristics, Biological [Group Attribute]
   753   C1521970:Characteristics [Qualitative Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.101: The P values reported in this study were not corrected for multiple testing and thus should be interpreted with caution. 

Phrase: "The P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "reported in this study"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   802   C1317750:Study report [Intellectual Product]
   802   C1831145:Study report [Clinical Attribute]
   770   C0557651:Study [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C2603343:Study [Research Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "corrected for multiple testing"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0039593:Testing [Functional Concept]
   770   C0205202:Corrected [Qualitative Concept]
   770   C0392366:testing [Intellectual Product]
   770   C0439064:Multiple [Quantitative Concept]
   737 E C2349182:Correct [Qualitative Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "should"

Phrase: "be"

Phrase: "interpreted with caution."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1285553:interpreted [Functional Concept]
Processing 00000000.tx.102: It is unclear what level of correction should be applied; 

Phrase: "It"

Phrase: "is"

Phrase: "unclear"

Phrase: "what level of correction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "should"

Phrase: "be"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: ";"
Processing 00000000.tx.103: i.e. whether each polymorphism should be viewed as a separate test (corrected by multiplying by 10), or if each gene should be considered separately (correction of IL-1A by multiplying by 1, IL-1B by multiplying by 4 and IL-1 RA by multiplying by 5). 

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "whether"

Phrase: "each polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "should"

Phrase: "be"

Phrase: "viewed as a separate test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0443299:Separate [Spatial Concept]
   726   C0449911:View [Spatial Concept]

Phrase: "("

Phrase: "corrected by multiplying"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205202:Corrected [Qualitative Concept]
   756   C1719797:Multiply [Functional Concept]
   756 E C2349182:Correct [Qualitative Concept]
   756   C2911648:Multiply [Quantitative Concept]

Phrase: "by 10"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "if"

Phrase: "each gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "should"

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "separately"

Phrase: "(correction of IL-1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705565:CORRECTION [Intellectual Product]
   770   C1947976:Correction [Functional Concept]

Phrase: "by multiplying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1719797:Multiply [Functional Concept]
   966   C2911648:Multiply [Quantitative Concept]

Phrase: "by 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "IL-1B by multiplying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0450345:1B [Intellectual Product]

Phrase: "by 4"

Phrase: "and"

Phrase: "IL-1 RA by multiplying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3538806:Ra [Spatial Concept]

Phrase: "by 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.104: Given the evidence of strong linkage disequilibrium between the polymorphic sites, it is very difficult to analyse these polymorphisms independently. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the evidence of strong linkage disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "between the polymorphic sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "it"

Phrase: "is"

Phrase: "very difficult to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332218:Difficult [Qualitative Concept]
   827   C0442824:Very [Qualitative Concept]
   755 E C1299586:Difficulty [Finding]

Phrase: "analyse"

Phrase: "these polymorphisms independently."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.105: In conclusion, this study suggests that IL-1 gene cluster polymorphisms are associated with an increased risk for Behet's disease. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that IL-1 gene cluster polymorphisms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   853   C0678951:gene polymorphisms [Genetic Function]
   804   C0032529:polymorphisms [Genetic Function]
   771 E C1882417:Polymorphism [Qualitative Concept]
   717   C1708431:Interleukin 1 Gene [Gene or Genome]

Phrase: "are"

Phrase: "associated with an increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.106: These polymorphisms may contribute to the enhanced inflammatory reactivity observed in patients with Behet's disease. 

Phrase: "These polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "contribute to the enhanced inflammatory reactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0333348:Inflammatory [Functional Concept]
   753   C1880177:Contribute [Activity]
   753   C2349975:Enhanced [Activity]

Phrase: "observed in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1441672:Observed [Functional Concept]

Phrase: "with Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.107: Association of IL-1 gene cluster polymorphisms with Behet's disease in other ethnic groups or its relationship with specific manifestations or severity of Behet's disease needs to be further studied.  

Phrase: "Association of IL-1 gene cluster polymorphisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in other ethnic groups"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0015031:Ethnic Groups [Population Group]
           ETHNIC
   966 E C1879937:Ethnic Group [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0680174:ethnic [Finding]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "or"

Phrase: "its relationship with specific manifestations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "or"

Phrase: "severity of Behet's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0521117:disease severity [Qualitative Concept]
   770   C0439793:Severity [Qualitative Concept]
   770   C2983285:Severity [Intellectual Product]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.108: Notes  Correspondence to: W. 

Phrase: "Notes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "W."
Processing 00000000.tx.109: E. 

Phrase: "E."
Processing 00000000.tx.110: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.111: Ollier, The Centre for Integrated Genomic Medical Research, Manchester University, Medical School, Stopford Building, Oxford Road, Manchester M13 9PT, UK. 

Phrase: "Ollier,"

Phrase: "The Centre for Integrated Genomic Medical Research,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   774   C0683939:center research [Manufactured Object,Organization]
   774   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   748   C0205099:Center [Spatial Concept]

Phrase: "Manchester University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   861   C0036375:School [Manufactured Object,Organization]

Phrase: "Stopford Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547706:Building [Functional Concept]
   861   C1999269:Building [Manufactured Object]

Phrase: "Oxford Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442650:Road [Manufactured Object]

Phrase: "Manchester M13 9PT,"

Phrase: "UK."
Processing 00000000.tx.112: E-mail: bill{at}fs1.ser.man.ac.uk  References Top Abstract Introduction Patients and methods Results Discussion References  Jorizzo JL, Solomon AR, Cavallo T. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "bill{at}fs1.ser.man.ac.uk"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Jorizzo JL,"

Phrase: "Solomon AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: "Cavallo T."
Processing 00000000.tx.113: Behet's syndrome. 

Phrase: "Behet's syndrome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039082:Syndrome [Disease or Syndrome]
Processing 00000000.tx.114: Immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up. 

Phrase: "Immunopathologic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0596756:Immunopathology [Biomedical Occupation or Discipline]
   928   C1555821:Immunopathology [Intellectual Product]
   928   C1609432:Immunopathology [Disease or Syndrome]

Phrase: "and"

Phrase: "histopathologic assessment of pathergy lesions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "is"

Phrase: "useful in diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   718   C0042153:use [Functional Concept]
   718   C0457083:Use [Functional Concept]
   718   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "follow-up."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0589120:Follow-up [Finding]
  1000   C1522577:follow-up [Health Care Activity]
  1000   C1704685:FOLLOW-UP [Intellectual Product]
  1000   C3274571:FOLLOW-UP [Health Care Activity]
   861   C0332283:follow [Temporal Concept]
   861   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.115: Arch Pathol Lab Med 1985;109:74751.[ISI][Medline] Sakane T, Takeno M, Suzuki N, Inaba G. 

Phrase: "Arch Pathol Lab Med 1985"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0022877:Lab [Manufactured Object,Organization]
   804   C0230467:arch [Body Location or Region]
   804   C0741204:ARCH [Body Space or Junction]
   748 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   721 E C0587081:Labs [Finding]

Phrase: ";109"

Phrase: ":"

Phrase: "74751."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sakane T,"

Phrase: "Takeno M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Suzuki N,"

Phrase: "Inaba G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.116: Behet's disease. 

Phrase: "Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.117: N Engl J Med 1999;341:128491.[Free FullText] International study group for Behet's disease. 

Phrase: "N Engl J Med 1999"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ";341"

Phrase: ":"

Phrase: "128491."

Phrase: "[Free FullText"

Phrase: "] International study group for Behet's disease."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0441833:Group [Idea or Concept]
   753   C0557651:Study [Manufactured Object]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1512888:International [Idea or Concept]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C2603343:Study [Research Activity]
Processing 00000000.tx.118: Criteria for diagnosis of Behet's disease. 

Phrase: "Criteria for diagnosis of Behet's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.119: Lancet 1990;335. 

Phrase: "Lancet 1990"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ";335."
Processing 00000000.tx.120: Kaklamani VG, Vaiopoulos G, Kaklamanis PG. 

Phrase: "Kaklamani VG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205999:VG [Geographic Area]

Phrase: "Vaiopoulos G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Kaklamanis PG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]
Processing 00000000.tx.121: Behet's disease. 

Phrase: "Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.122: Semin Arthritis Rheum 1998;27:197217.[ISI][Medline] Yurdakul S, Gunaydin I, Tuzun Y et al. 

Phrase: "Semin Arthritis Rheum 1998"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0003864:Arthritis [Disease or Syndrome]
   812   C0035431:Rheum [Plant]
   719 E C0018099:Gout [Disease or Syndrome]

Phrase: ";27"

Phrase: ":"

Phrase: "197217."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yurdakul S,"

Phrase: "Gunaydin I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tuzun Y et al."
Processing 00000000.tx.123: The prevalence of Behet's syndrome in a rural area in northern Turkey. 

Phrase: "The prevalence of Behet's syndrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033105:Prevalence [Quantitative Concept]
   760   C0220900:prevalence [Quantitative Concept]

Phrase: "in a rural area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178837:rural area [Spatial Concept]
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "in northern Turkey."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041400:Turkey [Geographic Area]
   861   C0325628:Turkey, NOS [Bird]
   861   C2348826:TURKEY [Food]
Processing 00000000.tx.124: J Rheumatol 1988;15:8202.[ISI][Medline] Ohno S, Asanuma T, Sugiura S, Wakisaka A, Aizawa M, Itakura K. 

Phrase: "J Rheumatol 1988"

Phrase: ";15"

Phrase: ":"

Phrase: "8202."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ohno S,"

Phrase: "Asanuma T,"

Phrase: "Sugiura S,"

Phrase: "Wakisaka A,"

Phrase: "Aizawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Itakura K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.125: HLA-Bw51 and Behet's disease. 

Phrase: "HLA-Bw51"

Phrase: "and"

Phrase: "Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.126: J Am Med Assoc 1978;240:529. 

Phrase: "J"

Phrase: "Am"

Phrase: "Med Assoc 1978"

Phrase: ";240"

Phrase: ":"

Phrase: "529."
Processing 00000000.tx.127: Koumantaki Y, Stavropoulos C, Spyropoulou M et al. 

Phrase: "Koumantaki Y,"

Phrase: "Stavropoulos C,"

Phrase: "Spyropoulou M et al."
Processing 00000000.tx.128: HLA-B*5101 in Greek patients with Behet's disease. 

Phrase: "HLA-B*5101 in Greek patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0019737:HLA-B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0550853:HLA-B [Clinical Attribute]
   790   C1415561:HLA-B [Gene or Genome]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0337806:GREEK [Population Group]

Phrase: "with Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.129: Hum Immunol 1998;59:2505.[CrossRef][ISI][Medline] Gul A, Inanc M, Ocal L, Aral O, Konice M. 

Phrase: "Hum Immunol 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";59"

Phrase: ":"

Phrase: "2505."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gul A,"

Phrase: "Inanc M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ocal L,"

Phrase: "Aral O,"

Phrase: "Konice M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.130: Familial aggregation of Behet's disease in Turkey. 

Phrase: "Familial aggregation of Behet's disease"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "in Turkey."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041400:Turkey [Geographic Area]
  1000   C0325628:Turkey, NOS [Bird]
  1000   C2348826:TURKEY [Food]
Processing 00000000.tx.131: Ann Rheum Dis 2000;59:6225.[Abstract/Free FullText] Sakane T, Kotani H, Takada S, Tsunematsu T. 

Phrase: "Ann Rheum Dis 2000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0035431:Rheum [Plant]
   812   C0451119:DIS [Intellectual Product]
   812   C1444662:DIS [Finding]

Phrase: ";59"

Phrase: ":"

Phrase: "6225."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sakane T,"

Phrase: "Kotani H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Takada S,"

Phrase: "Tsunematsu T."
Processing 00000000.tx.132: Functional aberration of T cell subsets in patients with Behet's disease. 

Phrase: "Functional aberration of T cell subsets"

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.133: Arthritis Rheum 1982;25:134351.[ISI][Medline] Niwa Y, Mizushima Y. 

Phrase: "Arthritis Rheum 1982"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0035431:Rheum [Plant]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: ";25"

Phrase: ":"

Phrase: "134351."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Niwa Y,"

Phrase: "Mizushima Y."
Processing 00000000.tx.134: Neutrophil-potentiating factors released from stimulated lymphocytes; 

Phrase: "Neutrophil-potentiating factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "released from stimulated lymphocytes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0024264:Lymphocytes [Cell]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1948023:Stimulated [Natural Phenomenon or Process]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.135: special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behet's disease. 

Phrase: "special reference to the increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]

Phrase: "in neutrophil-potentiating factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "from streptococcus-stimulated lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024264:Lymphocytes [Cell]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.136: Clin Exp Immunol 1990;79:35360.[ISI][Medline] Carletto A, Pacor ML, Biasi D et al. 

Phrase: "Clin Exp Immunol 1990"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1315013:CLIN [Intellectual Product]
   812   C1417055:EXP [Gene or Genome]
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";79"

Phrase: ":"

Phrase: "35360."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carletto A,"

Phrase: "Pacor ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Biasi D et al."
Processing 00000000.tx.137: Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behet's disease. 

Phrase: "Changes of neutrophil migration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "without modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "of in vitro metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "adhesion in Behet's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.138: J Rheumatol 1997;24:13326.[ISI][Medline] Mege JL, Dilsen N, Sanguedolce V et al. 

Phrase: "J Rheumatol 1997"

Phrase: ";24"

Phrase: ":"

Phrase: "13326."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mege JL,"

Phrase: "Dilsen N,"

Phrase: "Sanguedolce V et al."
Processing 00000000.tx.139: Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behet's disease. 

Phrase: "Overproduction of monocyte derived tumor necrosis factor alpha,"

Phrase: "interleukin (IL) 6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021760:Interleukin-6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527132:interleukin 6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "IL-8"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0079633:Interleukin-8 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366571:INTERLEUKIN 8 [Gene or Genome]
  1000   C1527432:Interleukin-8 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "increased neutrophil superoxide generation in Behet's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]
Processing 00000000.tx.140: A comparative study with familial Mediterranean fever and healthy subjects. 

Phrase: "A comparative study with familial Mediterranean fever"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0009491:Comparative Study [Intellectual Product]
   778   C1579762:comparative study [Research Activity]
   774   C0199236:Familial Study [Diagnostic Procedure]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "healthy subjects."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1708335:HEALTHY SUBJECTS [Population Group]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.141: J Rheumatol 1993;20:15449.[ISI][Medline] Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroglu IC, Dundar S, Kirazli S. 

Phrase: "J Rheumatol 1993"

Phrase: ";20"

Phrase: ":"

Phrase: "15449."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sayinalp N,"

Phrase: "Ozcebe OI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029434:OI [Congenital Abnormality,Disease or Syndrome]

Phrase: "Ozdemir O,"

Phrase: "Haznedaroglu IC,"

Phrase: "Dundar S,"

Phrase: "Kirazli S."
Processing 00000000.tx.142: Cytokines in Behet's disease. 

Phrase: "Cytokines in Behet's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.143: J Rheumatol 1996;23:3212.[ISI][Medline] Yosipovitch G, Shohat B, Bshara J, Wysenbeek A, Weinberger A. 

Phrase: "J Rheumatol 1996"

Phrase: ";23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "3212."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yosipovitch G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Shohat B,"

Phrase: "Bshara J,"

Phrase: "Wysenbeek A,"

Phrase: "Weinberger A."
Processing 00000000.tx.144: Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behet's disease: correlations with disease activity and severity. 

Phrase: "Elevated serum interleukin 1 receptors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0063710:Receptors, Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   867 E C1416395:INTERLEUKIN 1 RECEPTOR [Gene or Genome]
   853   C0206553:Receptors, Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "interleukin 1B in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0450345:1B [Intellectual Product]

Phrase: "with Behet's disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "correlations with disease activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "severity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439793:Severity [Qualitative Concept]
  1000   C2983285:Severity [Intellectual Product]
   928 E C0205082:Severe [Qualitative Concept]
Processing 00000000.tx.145: Isr J Med Sci 1995;31:3458.[ISI][Medline] Hamzaoui K, Hamza M, Ayed K. 

Phrase: "Isr J Med Sci 1995"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0022271:ISR [Geographic Area]
   804   C3642273:SCI [Professional or Occupational Group]

Phrase: ";31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "3458."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hamzaoui K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hamza M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ayed K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.146: Production of TNF-alpha and IL-1 in active Behet's disease. 

Phrase: "Production of TNF-alpha"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C1819464:TNF-alpha production [Organism Function]
           TNF production
   770   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "IL-1 in active Behet's disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   799   C0012634:Disease [Disease or Syndrome]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.147: J Rheumatol 1990;17:14289.[ISI][Medline] Nothwang HG, Strahm B, Denich D et al. 

Phrase: "J Rheumatol 1990"

Phrase: ";17"

Phrase: ":"

Phrase: "14289."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nothwang HG,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025424:Hg [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C2347108:Hg+ [Element, Ion, or Isotope]
   861   C2347109:Hg++ [Element, Ion, or Isotope]
   861   C2348272:Hg [Element, Ion, or Isotope]

Phrase: "Strahm B,"

Phrase: "Denich D et al."
Processing 00000000.tx.148: Molecular cloning of the interleukin-1 gene cluster: construction of an integrated YAC/PAC contig and a partial transcriptional map in the region of chromosome 2q13. 

Phrase: "Molecular cloning of the interleukin-1 gene cluster"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   767   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0009015:Cloning [Research Activity]

Phrase: ":"

Phrase: "construction of an integrated YAC/PAC contig"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "a partial transcriptional map in the region of chromosome 2q13."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0814036:chromosome map [Intellectual Product]
   739   C0024779:Map [Manufactured Object]
   739   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.149: Genomics 1997;41:3708.[CrossRef][ISI][Medline] Durum SK, Schmidt JA, Oppenheim JJ. 

Phrase: "Genomics 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: ";41"

Phrase: ":"

Phrase: "3708."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Durum SK,"

Phrase: "Schmidt JA,"

Phrase: "Oppenheim JJ."
Processing 00000000.tx.150: Interleukin 1: an immunological perspective. 

Phrase: "Interleukin 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "an immunological perspective."
Processing 00000000.tx.151: Annu Rev Immunol 1985;3:26387.[CrossRef][ISI][Medline] Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B. 

Phrase: "Annu Rev Immunol 1985"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ";3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "26387."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bevilacqua MP,"

Phrase: "Stengelin S,"

Phrase: "Gimbrone MA,"

Phrase: "Seed B."
Processing 00000000.tx.152: Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. 

Phrase: "Endothelial leukocyte adhesion molecule 1"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0115305:Endothelial Leukocyte Adhesion Molecule-1 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
           endothelial leukocyte adhesion molecule
           Endothelial Adhesion Molecule 1
  1000   C1337114:ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 [Gene or Genome]
   884   C0034822:leukocyte adhesion molecule [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   875   C0054964:Leucocyte 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1154393:leukocyte adhesion [Cell Function]
   804   C0001511:Adhesion [Pathologic Function]
   804   C0014257:Endothelial [Tissue]
   804   C0023516:Leucocyte [Cell]
   804   C0175633:Adhesion [Natural Phenomenon or Process]
   804   C0567416:Molecule [Substance]
   733 E C1521991:Molecular [Qualitative Concept]

Phrase: ":"

Phrase: "An inducible receptor for neutrophils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "complement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "regulatory proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]

Phrase: "and"

Phrase: "lectins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023206:Lectins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.153: Science 1989;243:11605.[ISI][Medline] Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. 

Phrase: "Science 1989"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ";243"

Phrase: ":"

Phrase: "11605."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dustin ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Rothlein R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bhan AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Dinarello CA,"

Phrase: "Springer TA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]
Processing 00000000.tx.154: Induction by IL-1, and interferon-: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). 

Phrase: "Induction by IL-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "interferon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "Tissue distribution,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040287:Tissue Distribution [Quantitative Concept]
  1000   C0220927:tissue distribution [Functional Concept]
   861   C0040300:Tissue [Tissue]
   861   C0520511:distribution [Idea or Concept]
   861   C1547928:Tissue [Intellectual Product]
   861   C1704711:Distribution [Functional Concept]

Phrase: "biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "function of a natural adherence molecule"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
   748   C1148560:molecular function [Molecular Function]

Phrase: "(ICAM-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0063695:ICAM-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334074:ICAM1 [Gene or Genome]
   861   C0598077:I-CAM [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.155: J Immunol 1986;137:24554.[Abstract/Free FullText] Wellicome SM, Thornhill MH, Thomas DS et al. 

Phrase: "J Immunol 1986"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";137"

Phrase: ":"

Phrase: "24554."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wellicome SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Thornhill MH,"

Phrase: "Thomas DS et al."
Processing 00000000.tx.156: A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1 or lipopolysaccharide. 

Phrase: "A monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "that"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a novel antigen on endothelial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0348042:A antigen [Immunologic Factor]
   753   C0003320:Antigen [Immunologic Factor]

Phrase: "that"

Phrase: "is"

Phrase: "induced by tumor necrosis factor,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   862   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   862   C1323304:tumor necrosis factor [Molecular Function]
   862   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C0333516:Tumor necrosis [Neoplastic Process]
   762 E C1300818:Necrotic tumor [Neoplastic Process]
   760   C0027540:Necrosis [Organ or Tissue Function]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0205263:Induced [Functional Concept]
   760   C1334928:Necrosis [Finding]
   760   C1521761:Factor [Functional Concept]
   760   C1578706:Tumor [Intellectual Product]
   760   C2827422:Factor [Conceptual Entity]
   760   C3273930:Tumor [Finding]

Phrase: "IL-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "lipopolysaccharide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023810:Lipopolysaccharide [Lipid]
Processing 00000000.tx.157: J Immunol 1990;144:255865.[Abstract/Free FullText] McDowell TL, Symons JA, Ploski R, Forre O, Duff GW. 

Phrase: "J Immunol 1990"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";144"

Phrase: ":"

Phrase: "255865."

Phrase: "[Abstract/Free FullText"

Phrase: "] McDowell TL,"

Phrase: "Symons JA,"

Phrase: "Ploski R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Forre O,"

Phrase: "Duff GW."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]
Processing 00000000.tx.158: A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. 

Phrase: "A genetic association between juvenile rheumatoid arthritis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1328885:genetic association [Occupation or Discipline]
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "a novel interleukin-1 alpha polymorphism."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0032529:Polymorphism [Genetic Function]
   804   C1882417:Polymorphism [Qualitative Concept]
   717   C0600251:Interleukin-1 alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
   717   C1334111:INTERLEUKIN 1-ALPHA [Gene or Genome]
   717   C1523980:interleukin-1-alpha [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.159: Arthritis Rheum 1995;38:2218.[ISI][Medline] di Giovine FS, Takhsh E, Blakemore AI, Duff GW. 

Phrase: "Arthritis Rheum 1995"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0035431:Rheum [Plant]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: ";38"

Phrase: ":"

Phrase: "2218."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] di Giovine FS,"

Phrase: "Takhsh E,"

Phrase: "Blakemore AI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003353:AI [Geographic Area]
   861   C0003504:ai [Disease or Syndrome]

Phrase: "Duff GW."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]
Processing 00000000.tx.160: Single base polymorphism at 511 in the human interleukin-1 beta gene (IL1 beta). 

Phrase: "Single base polymorphism at 511"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0752046:Polymorphism, Single Base [Nucleotide Sequence]
   760   C0032529:Polymorphism [Genetic Function]
   760   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in the human interleukin-1 beta gene (IL1 beta)."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C1708431:Interleukin-1-Beta Gene [Gene or Genome]
           Interleukin 1 Gene
   897   C0314604:Human gene [Gene or Genome]
   875   C1334205:Interleukin Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   717   C0021753:Interleukin-1 beta [Amino Acid, Peptide, or Protein,Immunologic Factor]
   717   C1334112:INTERLEUKIN 1-BETA [Gene or Genome]
   717   C1522432:interleukin-1-beta [Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.161: Hum Mol Genet 1992;1:450. 

Phrase: "Hum Mol Genet 1992"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ";1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "450."
Processing 00000000.tx.162: Guasch JF, Bertina RM, Reitsma PH. 

Phrase: "Guasch JF,"

Phrase: "Bertina RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Reitsma PH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.163: Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. 

Phrase: "Five novel intragenic dimorphisms in the human interleukin-1 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0598095:dimorphism [Organ or Tissue Function]

Phrase: "combine to high informativity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205250:High [Qualitative Concept]
   770   C0336789:Combine [Manufactured Object]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.164: Cytokine 1996;8:598602.[CrossRef][ISI][Medline] Tarlow JK, Blakemore AI, Lennard A et al. 

Phrase: "Cytokine 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";8"

Phrase: ":"

Phrase: "598602."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tarlow JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "Blakemore AI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003353:AI [Geographic Area]
   861   C0003504:ai [Disease or Syndrome]

Phrase: "Lennard A et al."
Processing 00000000.tx.165: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. 

Phrase: "Polymorphism in human IL-1 receptor antagonist gene intron 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0678951:gene polymorphism [Genetic Function]
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "caused by variable numbers of an 86-bp tandem repeat."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   781   C0242827:Variable Number Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   781   C1710347:Variable Number Tandem Repeat [Cell or Molecular Dysfunction]
   777   C3179163:Variable Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0039290:Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   739   C0205341:Repeat [Functional Concept]
   739   C0237753:*Number [Quantitative Concept]
   739   C0439828:Variable [Qualitative Concept]
   739   C0449788:Number [Quantitative Concept]
   739   C1547730:Repeat [Temporal Concept]
   739   C1705914:Repeat [Conceptual Entity]
   706   C0015127:cause [Functional Concept]
   706   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.166: Hum Genet 1993;91:4034.[ISI][Medline] Terwilliger J, Ott J. 

Phrase: "Hum Genet 1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ";91"

Phrase: ":"

Phrase: "4034."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Terwilliger J,"

Phrase: "Ott J."
Processing 00000000.tx.167: Chapter 23. 

Phrase: "Chapter 23."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450348:23 [Quantitative Concept]
   861   C1552857:chapter [Idea or Concept]
Processing 00000000.tx.168: Handbook of human genetic linkage. 

Phrase: "Handbook of human genetic linkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596654:handbook [Intellectual Product]
Processing 00000000.tx.169: Baltimore: Johns Hopkins University Press, 1994:18898. 

Phrase: "Baltimore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: ":"

Phrase: "Johns Hopkins University Press,"

Phrase: "1994"

Phrase: ":"

Phrase: "18898."
Processing 00000000.tx.170: Stephens M, Smith NJ, Donnelly P. 

Phrase: "Stephens M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Smith NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Donnelly P."
Processing 00000000.tx.171: A new statistical method for haplotype reconstruction from population data. 

Phrase: "A new statistical method for haplotype reconstruction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1710191:Statistical Method [Research Activity]
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "from population data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.172: Am J Hum Genet 2001;68:97889.[CrossRef][ISI][Medline] Katayama T, Tachinami K, Ishiguro M, Kubota Y. 

Phrase: "Am"

Phrase: "J Hum Genet 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ";68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "97889."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Katayama T,"

Phrase: "Tachinami K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ishiguro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kubota Y."
Processing 00000000.tx.173: The relation between Behet's disease and interleukin-1 beta production. 

Phrase: "The relation between Behet's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0080103:Relation [Family Group]
   760   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "interleukin-1 beta production."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1819435:interleukin-1 beta production [Organism Function]
   923   C1819436:interleukin-1 production [Organism Function]
   902   C3159141:interleukin production [Organism Function]
   812   C0033268:production [Occupational Activity]
   756   C0021753:Interleukin-1 beta [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C1334112:INTERLEUKIN 1-BETA [Gene or Genome]
   756   C1522432:interleukin-1-beta [Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.174: Nippon Ganka Gakkai Zasshi 1994;98:197201.[Medline] Du Y, Dodel RC, Eastwood BJ et al. 

Phrase: "Nippon Ganka Gakkai Zasshi 1994"

Phrase: ";98"

Phrase: ":"

Phrase: "197201."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Du Y,"

Phrase: "Dodel RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Eastwood BJ et al."
Processing 00000000.tx.175: Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. 

Phrase: "Association of an interleukin 1 alpha polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.176: Neurology 2000;55:4803.[Abstract/Free FullText] van den Velden PA, Reitsma PH. 

Phrase: "Neurology 2000"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ":"

Phrase: "4803."

Phrase: "[Abstract/Free FullText"

Phrase: "] van den Velden PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3541314:PA [Idea or Concept]

Phrase: "Reitsma PH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.177: Amino-acid dimorphism in IL1A is detectable by PCR amplification. 

Phrase: "Amino-acid dimorphism in IL1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0598095:dimorphism [Organ or Tissue Function]

Phrase: "is"

Phrase: "detectable by PCR amplification."
Processing 00000000.tx.178: Hum Mol Genet 1993;2:1753. 

Phrase: "Hum Mol Genet 1993"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ";2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1753."
Processing 00000000.tx.179: Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, van Deventer SJ. 

Phrase: "Stokkers PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "van Aken"

Phrase: "BE"

Phrase: ","

Phrase: "Basoski N,"

Phrase: "Reitsma PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Tytgat GN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018381:GN [Geographic Area]

Phrase: "van Deventer SJ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1515101:SJ [Geographic Area]
   827   C2986905:SJ [Idea or Concept]
Processing 00000000.tx.180: Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. 

Phrase: "Five genetic markers in the interleukin 1 family"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0017393:Genetic Markers [Genetic Function]
   770   C0600223:genetic markers [Laboratory Procedure]
   744   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   744   C0314603:Genetic [Functional Concept]
   739   C0870545:family origins [Family Group]
   711   C0005516:Marker [Clinical Attribute]

Phrase: "in relation to inflammatory bowel disease."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021390:Inflammatory bowel disease [Disease or Syndrome]
   913   C1290884:Inflammatory disease [Disease or Syndrome]
   901   C0021831:bowel disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0021853:Bowel [Body Part, Organ, or Organ Component]
   827   C0333348:Inflammatory [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.181: Gut 1998;43:339.[Abstract/Free FullText] Loughrey BV, Maxwell AP, Fogarty DG et al. 

Phrase: "Gut 1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017189:Gut [Body System]
   861   C0699819:Gut [Body Part, Organ, or Organ Component]

Phrase: ";43"

Phrase: ":"

Phrase: "339."

Phrase: "[Abstract/Free FullText"

Phrase: "] Loughrey BV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511278:BV [Geographic Area]

Phrase: "Maxwell AP,"

Phrase: "Fogarty DG et al."
Processing 00000000.tx.182: An interleukin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. 

Phrase: "An interleukin 1B allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "which"

Phrase: "correlates with a high secretor phenotype,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031437:Phenotype [Organism Attribute]
   753   C0205250:High [Qualitative Concept]
   753   C1285572:Phenotype [Laboratory Procedure]
   753   C1299351:High [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "is"

Phrase: "associated with diabetic nephropathy."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0011881:Diabetic Nephropathy [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1442864:diabetic nephropathy [Gene or Genome]
   770   C0022658:Nephropathy [Disease or Syndrome]
   770   C0241863:DIABETIC [Finding]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.183: Cytokine 1998;10:9848.[CrossRef][ISI][Medline] Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. 

Phrase: "Cytokine 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";10"

Phrase: ":"

Phrase: "9848."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pociot F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Molvig J,"

Phrase: "Wogensen L,"

Phrase: "Worsaae H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nerup J."
Processing 00000000.tx.184: A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. 

Phrase: "A TaqI polymorphism in the human interleukin-1 beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1839238:TaqI POLYMORPHISM [Disease or Syndrome]
   742   C0032529:Polymorphism [Genetic Function]
   742   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(IL-1 beta"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0021753:Interleukin-1 beta [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334112:INTERLEUKIN 1-BETA [Gene or Genome]
  1000   C1522432:interleukin-1-beta [Immunologic Factor,Pharmacologic Substance]
   901   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "correlates with IL-1 beta secretion"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   882   C1327420:interleukin-1 beta secretion [Cell Function]
   833   C0021753:Interleukin-1 beta [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C1334112:INTERLEUKIN 1-BETA [Gene or Genome]
   833   C1522432:interleukin-1-beta [Immunologic Factor,Pharmacologic Substance]
   820   C1327415:interleukin-1 secretion [Cell Function]
   790   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   783   C3155041:interleukin secretion [Cell Function]
   753   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0330390:Beta [Plant]
   753   C0439096:Beta [Intellectual Product]
   753   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C2004068:Beta [Qualitative Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.185: Eur J Clin Invest 1992;22:396402.[ISI][Medline] Submitted 22 July 2002; 

Phrase: "Eur J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "1992"

Phrase: ";22"

Phrase: ":"

Phrase: "396402."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "22 July 2002"

Phrase: ";"
Processing 00000000.tx.186: Accepted 3 December 2002 This Article Abstract Full Text (PDF) All Versions of this Article: 42/7/860 most recent keg232v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (6) Disclaimer Request Permissions Google Scholar Articles by Karasneh, J. 

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "3 December 2002"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "42/7/860 most recent keg232v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "for citing articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706852:Article [Intellectual Product]

Phrase: "in"

Phrase: ":"

Phrase: "ISI Web of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282111:Web [Manufactured Object]

Phrase: "(6"

Phrase: ")"

Phrase: "Disclaimer Request Permissions Google Scholar Articles by Karasneh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.187: Articles by Gul, A. 

Phrase: "Articles by Gul,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.188: PubMed PubMed Citation Articles by Karasneh, J. 

Phrase: "PubMed PubMed Citation Articles by Karasneh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.189: Articles by Gul, A. 

Phrase: "Articles by Gul,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.190: Related Collections Other Rheumatology Online ISSN 1462-0332 - Print ISSN 1462-0324 Copyright  2006 British Society for Rheumatology Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Related Collections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0600644:Collections [Intellectual Product]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   777 E C1516695:Collected [Idea or Concept]

Phrase: "Other Rheumatology Online ISSN 1462-0332 - Print ISSN 1462-0324 Copyright  2006 British Society"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0037455:society [Organization]

Phrase: "for Rheumatology Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   801   C2735290:Privacy policy [Intellectual Product]
   788   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

